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ABSTRACT
Background    Oxidative stress plays an important role 
in the pathogenesis of bronchial asthma. Antioxidant nu-
trition and supplementation have been used to reduce ox-
idative stress. However, a clinical trial with antioxidant 
supplementation showed no beneficial effects in patients 
with asthma. On the other hand, physical activity is re-
lated to the prognosis of chronic obstructive pulmonary 
disease (COPD) and is also related to oxidant status. We 
investigated the relationships between oxidative stress, 
serum levels of vitamins, dietary vitamin intake, daily 
activities, and pulmonary functions in patients with asth-
ma. 
Methods    Eighteen patients with bronchial asthma 
were enrolled in this study. Reactive oxidative stress was 
assessed by measuring organic hydroperoxides (diacron 
reactive oxygen metabolites: dROM) in sera and by mea-
suring H2O2 levels in exhaled breath condensates. The 
biological antioxidant capacity in serum was evaluated 
by measuring antioxidant potential capacity against fer-
ric ion. We also assessed pulmonary functions, fraction 
of exhaled nitric oxide, serum levels of vitamins, dietary 
vitamin intake, and physical activities. 
Results    There were no relationships between the index 
of oxidative stress (dROM and H2O2 in exhaled breathe 
condensates) and pulmonary functions, serum levels of 
vitamins, daily vitamin intakes, and activity levels in 
patients with asthma. 
Conclusion    The status of transient oxidative stress 
may not be related to daily activities, vitamin levels, 
and pulmonary functions in patients with asthma in a 
real-life setting. However, our results were obtained in 
the short-term period from a small number of subjects, 
so a large longitudinal study is required to ascertain the 
relationships between oxidative stress, physical activity 
and vitamin intake in patients with asthma.
Key words    asthma; exhaled breath condensate; oxida-
tive stress; vitamin
Oxidative stress is one of the risk factors for develop-
ing and for exacerbating atherosclerosis, cardiovascu-
lar disease, and respiratory diseases, such as chronic 
obstructive disease (COPD) and bronchial asthma.1–4 
In the pathogenesis of asthma, eosinophilic airway in-
flammation induces asthmatic symptoms and oxidative 
stress. Since eosinophils contain nicotinamide adenine 
dinucleotide phosphate oxidase, eosinophilic peroxidase, 
and nitric oxide synthesis, reactive oxygen species can 
be generated in the asthmatic airway.5, 6 A recent study 
in a mouse model showed that house dust mites increase 
oxidative stress.7 Furthermore, environmental stimuli, 
such as diesel exhaust particles, cigarette smoke, ozone, 
and viral infections, can result in increased reactive oxy-
gen species.8–11 Oxidative stress generated in the airway 
of patients with asthma causes epithelial cell injury. Fur-
thermore, reactive oxygen induces transforming growth 
factor-β1 secretion from epithelial cells,12 which may 
induce airway remodeling in asthma. Therefore, antioxi-
dants may be effective in the treatment of asthma.13
 The therapeutic strategies for protecting against ox-
idative stress are intake of antioxidants, such as dietary 
and vitamin supplementation (nutritional antioxidants), 
and chemical compounds or minerals, including N-ace-
tyl cysteine,14, 15 selenium, magnesium, and zinc.16 How-
ever, there are no clinical trial data suggesting that an-
tioxidants prevent asthma development. Furthermore, a 
few small clinical trials showed either improved asthma 
symptoms or pulmonary function.16–18 
 It has been reported that the level of physical activi-
ty is the one of the predictors of mortality in COPD pa-
tients.19, 20 Waschki et al reported that the level of physi-
cal activity is the strongest predictor compared to other 
established predictors, such as the ADO (age, dyspnea, 
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airflow obstruction) index, the BODE (BMI, airway 
obstruction, dyspnea, and exercise capacity) index, steps 
per day, forced expiratory volume in 1 second (FEV1)% 
predicted, and six-minute walk distance.19 Although 
physical activity has not been reported to improve asth-
matic symptoms, exercise improved asthmatic symp-
toms in adults and children.21–23 Furthermore, exercise 
reduced the antioxidant status in asthmatic children.24 
However, it has been reported that exercise induces oxi-
dative stress in humans.25, 26 A few clinical trials on exer-
cise-induced bronchoconstriction (EIB) found that some 
natural antioxidants, such as ascorbic acid, α-tocopherol, 
and lycopene, improved both asthma symptoms and 
pulmonary function.27–29 In summary, these studies on 
the relationship between physical activity, asthma, and 
oxidative stress are inconclusive. 
 In this study, we studied the correlations among ox-
idative stress, serum antioxidant levels, dietary intake of 
antioxidants, pulmonary function, and daily activities in 
patients with asthma in a real-life setting. 
SUBJECTS AND METHODS
Eighteen patients with bronchial asthma were enrolled in 
this study. Written informed consent was obtained from 
all of the patients. The diagnosis of asthma was made 
by respiratory physicians according to the American So-
ciety Criteria.30 No patient experienced deterioration of 
asthma symptoms from four weeks prior to enrollment 
of this study.
Assessment of oxidative stress and antioxidant 
potential in peripheral blood
Peripheral blood samples were collected from all pa-
tients on the first day of the enrollment of this study and 
stored at –20 °C until further analysis. Oxidative stress 
was assessed by a radical analyzer system (FREE Carpe 
Diem; Wismerll, Tokyo, Japan) according to the manu-
facturer’s instructions. In this study, we assessed oxida-
tive stress by measuring the diacron reactive oxygen me-
tabolite (dROM) which reflects organic hydroperoxides 
formed by oxidative stress. The results are expressed as 
U.Carr. One unit of U.Carr equals 0.8 mg/L of hydrogen 
peroxide in the serum.31 We also assessed the biological 
antioxidant potential (BAP). The BAP test reflects the 
antioxidant capacity in the serum by measuring the po-
tential capacity against ferric ions.    
Assessment of oxidative stress in exhaled breath 
condensates
All subjects breathed into an EcoScreen (Jaeger, Wurz-
burg, Germany) for 10 to 15 minutes to collect exhaled 
breath condensate (EBC) on the first day of the enroll-
ment of this study. The EBCs were stored at –20 °C until 
analyzed. The H2O2 level in the EBCs was measured by a 
radical analyzer system (FREE Carpe Diem; Wismerll). 
 
Measurement of respiratory functions
On the first day of the enrollment in this study, all pa-
tients were asked to perform a pulmonary function test 
with a Chestac 33 spirometer (Chest, Tokyo, Japan). 
Forced vital capacity (FVC) and FEV1 were recorded 
from a minimum of three pulmonary function tests. 
Percent (%) of vital capacity (VC) is the VC expressed 
as a percentage of the predicted values 32 and %FEV1 is 
the FEV1 expressed as a percentage of the predicted val-
ues.33
Measurement of fractional exhaled nitric oxide 
(FeNO)
The FeNO levels were measured using the Aerocrine 
NIOX MINO, a portable, hand-held NO analyzer (Aero-
crine AB, Solna, Sweden). In each measurement, partici-
pants were tested in a seated position without a nose clip 
with a constant flow rate of 50 mL/s. The measurement 
was performed once with each subject on the first day of 
enrollment in this study.
Measurement of serum vitamin levels 
Serum vitamin levels were measured in each patient 
on the first day of enrollment in this study. Fractions of 
vitamin E (α-tocopherol, β-tocopherol, γ-tocopherol, 
and δ-tocopherol), and the levels of retinol, and vitamin 
C were measured by high performance liquid chroma-
tography and 1,25 (OH)2 vitamin D was measured by 
radioimmunoassay. All vitamin levels in the serum were 
measured at SRL Inc. (Hachioji, Tokyo, Japan). 
Estimation of vitamin intake by a brief self-admin-
istered diet history questionnaire (BDHQ)
The intake of retinol, β-carotene, vitamin C, vitamin 
D, α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocoph-
erol, and cryptoxanthin was assessed based on results 
of a brief self-administered diet history questionnaire 
(BDHQ) version 1-1. The BDHQ used in this study was 
written in Japanese and supplied from EBNJAPAN 
(Tokyo, Japan). The questions in the BDHQ included 58 
on both food and beverage intake, and the frequency of 
food and beverage intake for the previous month was 
also included. 
Assessing activity by actigraphy
The actigraph accelerometer is worn like a light-weight 
wrist watch (Actiwatch 2; Philips Respironics, Murrys-
ville, PA). Actiwatch records a digitally-integrated mea-
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sure of gross motor activity, which can be used to quan-
titate rest and activity counts. The patients wore an acti-
graph for seven consecutive days, and the activity counts 
(AC) were collected. We defined 60 seconds as 1 epoch. 
Total activity counts were calculated by the following 
formula: total activity counts = 0.04E–2 + 0.020E–1 + E 
+ 0.2E+1 + 0.04E+2. E = activity counts during a scored 
epoch. En = activity counts during previous or successive 
epochs. We assessed total activity counts and total activity 
per minute according to the Actiwatch 5 software.
Statistical analysis
All the data were expressed as mean ± SD. The cor-
relations in the selected data sets were analyzed by 
Spearman’s correlation coefficients. GraphPad Prism 5 
(GraphPad Software, San Diego, CA) was used for all 
statistical analyses.
 This study was approved by the Ethics Committee 
of Tottori University (#1974) and was conducted accord-
ing to the principles of the Declaration of Helsinki. 
RESULTS
Characteristics of the patients 
In total, 18 patients were enrolled in this study. The aver-
age age of the patients was 63.3 years, and included eight 
Table 1. Characteristics of the patients
Number of patients, n 18
Age, years, mean ± SD 63.3 ± 11.2
Sex, n (%)
Male 8 (44.4)
Female 10 (55.6)
Smoking status, n (%)
Current 0 (0)
Ex-smoker 10 (55.6)
Non-smoker 8 (44.4)
FEV1/FVC, %, mean  ± SD 70.7 ± 9.8
%FEV1 predicted, %, mean ± SD 103.6 ± 19.7
%VC predicted, %, mean ± SD 111.7 ± 16.8
FeNO (ppb), mean ± SD 32.4 ± 18.3
FeNO, fractional exhaled nitric oxide; FEV1, forced expiratory 
volume in 1 second; FVC, forced vital capacity; VC vital capacity.
Table 2.  Actigraphy data  
Activity counts (24 h total), × 104, mean ± SD 260 ± 124
Activity counts per minutes, mean ± SD 283.3 ± 81.1
Table 3. Oxidative and antioxidative markers in pa-
tients with asthma
Oxidative and antioxidative markers Patients(n = 18)
Normal
range
dROM (U.Carr), mean ± SD 333.9 ± 49.7 < 300
BAP (μmol/L), mean ± SD 2363.2 ± 290.7 > 2200
H2O2 in EBC (μmol/L), mean ± SD 0.6 ± 0.3 0.23 ± 0.03*
*Adapted from reference 43. 
BAP, biological antioxidant potential; dROM, diacron reactive 
oxygen metabolite; EBC, exhaled breath condensate.
Table 4. Serum vitamin levels in patients with asthma
Serum vitamin levels Patients(n = 18)
Normal
range
Retinol (IU/dL) 156.1 ± 44.4 97–316
Vitamin C (μg/mL) 9.8 ± 3.6 5.5–16.8
1, 25 (OH)2 Vitamin D (pg/mL) 59.1 ± 15.6 20.0–60.0
Vitamin E fraction
α-tocopherol (mg/dL) 1.3 ± 0.3 0.49–1.09
β-tocopherol (mg/dL) 0.02 ± 0.006 < 0.02
γ-tocopherol (mg/dL) 0.09 ± 0.05 0.05–0.17
δ-tocopherol (mg/dL) Below detection limit < 0.01
males and 10 females of which 10 were ex-smokers and 
eight were non-smokers. The mean percentage of FEV1/
FVC was 70.7%, and the mean %FEV1 was 103.6%. The 
mean FeNO level was 32.4 ppb. (Table 1).
Actigraphy 
The average of total activity counts in 24 hours was 260 
× 104 counts. The activity counts per minutes were 283.3 
counts (Table 2).
Oxidative and antioxidative markers in patients 
with asthma
The average dROM level, an oxidant marker, was 333.9 
U.Carr. The average BAP level, another antioxidant 
marker, was 2363.2 mmol/L. The average H2O2 in the 
exhaled breath condensates was 0.6 mmol/L (Table 3). 
Serum vitamin levels in patients with asthma
Several vitamins with antioxidant capacity were mea-
sured. The average level of retinol was 156.1 IU/L, 
vitamin C was 9.8 μg/mL, 1,25 (OH)2 was 59.1 pg/mL. 
Among the fraction of vitamin E, the average level of 
α-tocopherol was 1.3 mg/dL, β-tocopherol was 0.02 mg/
dL, and γ-tocopherol was 0.09 mg/dL. The level of δ-to-
copherol was below the detection limit (Table 4). 
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Table 7. Relationships between dROM and pulmonary 
function, vitamin levels and activity counts
Spearman
r P-value
Pulmonary 
function
FEV1/FVC 0.08983 0.732
%FEV1 predicted 0.3283 0.1834
%VC predicted 0.253 0.3112
Serum level Retinol 0.2024 0.4206
Vitamin C 0.04134 0.8706
1,25 (OH)2 –0.1033 0.6835
Vitamin E –0.1177 0.6418
α-tocopherol 0.01809 0.9432
β-tocopherol 0.006814 0.9786
γ-tocopherol 0.06625 0.7939
Daily dietary 
intake
Retinol 0.2024 0.4206
β-carotene –0.1972 0.4328
Vitamin C –0.1074 0.6715
Vitamin D –0.3191 0.1969
α-tocopherol –0.3418 0.1651
β-tocopherol –0.2425 0.3323
γ-tocopherol –0.3717 0.1288
δ-tocopherol –0.3573 0.1456
Cryptoxanthin 0.06505 0.7976
Actigraphy 
date
Total activity counts 0.07537 0.7663
Activity counts/min 0.3748 0.1254
dROM, diacron reactive oxygen metabolite; FEV1, forced expi-
ratory volume in 1 second; FVC, forced vital capacity; VC vital 
capacity.
Daily vitamin intake estimated by BDHQ
The daily vitamin intake was estimated from the BDHQ. 
The average daily intake of retinol was 349.6 μg, β-caro-
tene was 5336.8 μg, vitamin C was 144.8 mg, vitamin D 
was 15.5 μg, α-tocopherol was 7.8 mg, β-tocopherol was 
0.4 mg, γ-tocopherol was 12.1 mg, δ-tocopherol was 3.3 
mg, and cryptoxanthin was 381.9 μg (Table 5). 
Relationships between dROM, BAP, and H2O2 in 
EBC
The correlations of dROM, BAP, and H2O2 in EBC were 
analyzed. There were no significant correlations be-
tween either dROM and BAP, dROM and H2O2 in EBC, 
or BAP and H2O2 (Table 6). 
Relationships between dROM and pulmonary 
function, vitamin levels, and actigraphy data
We examined the relationships between dROM and oth-
er parameters tested in this study. We could not find any 
significant correlation between dROM and either pul-
monary function, serum levels of vitamins, daily dietary 
intake of vitamins, or activity counts (Table 7).
Table 5.  Daily vitamin and provitamin intake estimat-
ed by BDHQ
Retinol (μg) 349.6 ± 290.0
β-carotene (μg) 5336.8 ± 3416.4
Vitamin C (mg) 144.8 ± 81.1
Vitamin D (μg) 15.5 ± 11.8
Vitamin E fraction 
α-tocopherol (mg) 7.8 ± 3.0
β-tocopherol (mg) 0.4 ± 0.1
γ-tocopherol (mg) 12.1 ± 3.9
δ-tocopherol (mg) 3.3 ± 1.3
Cryptoxanthin (μg) 381.9 ± 289.8
BDHQ, brief  self-administered diet history questionnaire.
Table 6. Relationships between dROM, BAP and H2O2 
in EBC
Spearman r P-value
BAP and dROM –0.2666 0.2848
H2O2 and dROM –0.3245 0.1888
H2O2 and BAP –0.4564 0.0569
BAP, biological antioxidant potential; dROM, diacron reactive 
oxygen metabolite; EBC, exhaled breath condensate.
Relationships between BAP and pulmonary func-
tion, vitamin levels, and actigraphy data
We next examined the relationships between BAP and 
additional parameters. In these comparisons, we could 
not find any significant correlation between BAP and ei-
ther pulmonary function, serum levels of vitamins, daily 
dietary intake of vitamins, or activity counts (Table 8).
Relationships between H2O2 in EBC and pulmo-
nary function, vitamin levels, and actigraphy data
We also examined the relationships between H2O2 in 
EBC and other parameters tested in this study. In these 
comparisons, we could not find any significant correla-
tion between H2O2 in EBC and either pulmonary func-
tion, serum levels of vitamins, daily dietary intake of 
vitamins, or activity counts (Table 9).
Relationships between activity counts and pulmo-
nary function 
Lastly, we examined the relationships between activity 
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Table 8.  Relationships between BAP and pulmonary 
function, vitamin levels and activity counts
Spearman
r P-value
Pulmonary 
function
FEV1/FVC –0.2941 0.2361
%FEV1 predicted –0.0774 0.7602
%VC predicted 0.02993 0.9062
Serum level Retinol –0.08678 0.7321
Vitamin C 0.2769 0.266
1,25 (OH)2 0.08772 0.7293
Vitamin E –0.1476 0.559
α-tocopherol –0.1198 0.6358
β-tocopherol 0.05572 0.8262
γ-tocopherol 0.02816 0.9117
Daily dietary 
intake
Retinol 0.06502 0.7977
β-carotene –0.1073 0.6717
Vitamin C –0.1084 0.6687
Vitamin D –0.2157 0.39
α-tocopherol –0.195 0.438
β-tocopherol 0.05572 0.8262
γ-tocopherol –0.02222 0.9303
δ-tocopherol –0.1078 0.6703
Cryptoxanthin 0.1199 0.6355
Actigraphy 
date
Total activity counts 0.1269 0.6157
Activity counts/min 0.01342 0.9579
BAP, biological antioxidant potential; FEV1, forced expiratory 
volume in 1 second; FVC, forced vital capacity; VC vital capacity.
Table 10. Relationships between activity counts and 
pulmonary function
Total activity counts
Spearman
r P-value
Pulmonary 
function
FEV1/FVC 0.3829 0.1168
%FEV1 predicted –0.08978 0.7231
%VC predicted 0.1620 0.5270
Activity counts/min
Spearman
r P–value
Pulmonary 
function
FEV1/FVC 0.6017 0.0083 
%FEV1 predicted 0.4118 0.0895
%VC predicted 0.2963 0.2798
FEV1, forced expiratory volume in 1 second; FVC, forced vital 
capacity; VC, vital capacity.
Table 9. Relationships between H2O2 in EBC and pul-
monary function, vitamin levels and activity counts
Spearman
r P-value
Pulmonary 
function
FEV1/FVC 0.08983 0.732
%FEV1 predicted 0.3283 0.1834
%VC predicted 0.253 0.3112
Serum level Retinol 0.2024 0.4206
Vitamin C 0.04134 0.8706
1,25 (OH)2 –0.1033 0.6835
Vitamin E –0.1177 0.6418
α-tocopherol 0.01809 0.9432
β-tocopherol 0.006814 0.9786
γ-tocopherol 0.06625 0.7939
Daily dietary 
intake
Retinol 0.2024 0.4206
β-carotene –0.1972 0.4328
Vitamin C –0.1074 0.6715
Vitamin D –0.3191 0.1969
α-tocopherol –0.3418 0.1651
β-tocopherol –0.2425 0.3323
γ-tocopherol –0.3717 0.1288
δ-tocopherol –0.3573 0.1456
Cryptoxanthin 0.06505 0.7976
Actigraphy 
date
Total activity counts 0.07537 0.7663
Activity counts/min 0.3748 0.1254
EBC, exhaled breath condensate; FEV1, forced expiratory volume 
in 1 second; FVC, forced vital capacity; VC vital capacity.
counts and pulmonary function. Total activity counts 
were not correlated with pulmonary function. Activity 
counts per minute were significantly correlated with 
FEV1/FVC. However, activity counts per minute were 
not correlated with percent FEV1 nor percent VC (Table 
10). 
DISCUSSION
In this study, we assessed the correlations among oxi-
dative stress, antioxidant capacity, dietary intake of an-
tioxidants, pulmonary functions, and daily activities in 
patients with asthma in a real-life setting. We found no 
significant relationships between the index of oxidative 
stress (dROM and H2O2 in exhaled breathe condensates) 
and pulmonary functions, levels of vitamin in serum, 
daily vitamin intakes, and activity counts in asthmatic 
patients. Our data suggest that oxidative stress is not 
affected by daily activity, intake of antioxidants, and 
pulmonary function in patients with asthma in a real-life 
setting. 
 We measured the dROM and BAP in sera and H2O2 
in exhaled breath condensates. These parameters can be 
measured from a small volume of either blood samples 
(dROM and BAP) or exhaled breath condensates (H2O2) 
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and can be evaluated for oxidative status. The level of 
dROM has been measured in various diseases.34–37 The 
international observational oxidative stress classified 
dROM levels into six stress levels as follows: Normal: < 
300 U.Carr, Borderline: 301-320 U.Carr, Low oxidative 
stress: 321-340 U.Carr, Middle oxidative stress: 341-400 
U.Carr, High oxidative stress: 401-500 U.Carr, and Very 
high oxidative stress: > 501 U.Carr.38 In our study, the 
average level of dROM was 333.9 U.Carr, which is clas-
sified as low oxidative stress. Suzuki et al. reported that 
the dROM level was constant in the stable condition and 
increased during acute exacerbation of asthma.39 They 
reported that the dROM level was 268.2 U.Carr in eleven 
stable asthmatic patients, while Nakamoto et al. reported 
the dROM level was 345 U.Carr in 110 stable asthmatic 
patients.40 Therefore, our result is almost consistent with 
the previous results. BAP level in patients with asthma 
is not yet well defined, the average BAP level in glauco-
ma patients is 1955.8 ± 276.7 μmol/L and about 2100 to 
2200 μmol/L in normal subjects.26, 41, 42 In our study, the 
average level of BAP was 2363 μmol/L, which is slight 
compared to previous results.26, 41, 42 It has been report-
ed that a BAP level above 2200 μmol/L is considered 
to have a normal biological antioxidant potential42 and 
an increased BAP level possibly counteracts increased 
levels of exercise-induced reactive oxygen species.26 
Therefore, elevated levels of BAP might be related to 
elevated levels of dROM. Further study is necessary to 
ascertain the relationships between levels of dROM and 
BAP in the same patients with repeated measurements. 
The H2O2 levels in EBC from patients with asthma have 
been reported in previous studies, and the levels of H2O2 
ranged from 0.238 to 0.91.43–45 These levels are consis-
tent with our study. 
 Although the levels of dROM, BAP, and H2O2 are 
consistent with previous studies, we could not find any 
relationships among pulmonary function tests and these 
parameters. Suzuki et al. reported that the dROM level 
is increased during acute exacerbation of asthma and is 
correlated with serum inflammatory mediators.39 Mura-
ta et al. reported that no relationships were observed in 
H2O2 levels and pulmonary functions46 while Al-Oba-
dity reported an inverse correlation between H2O2 and 
FEV1 percent predicted.43 Therefore, these oxidative 
stress markers may show a strong correlation with in-
flammatory markers, and not with pulmonary functions 
in patients with asthma.
 A variety of antioxidant supplements and nutrients 
has been studied for the treatment of asthma.16, 47 A few 
studies have shown the beneficial effect of antioxidants on 
pulmonary functions and on asthmatic symptoms.17, 18 In 
our study, we studied the relationships between oxida-
tive stress markers and either vitamins in serum or the 
daily intake of vitamins over a very short period, and 
no relationships were found. Therefore, no clear and ob-
vious relationships may exist in antioxidant vitamins or 
nutrition in a real-life setting. It should be noted that the 
number of subjects was small, and the duration of our 
study was very short. 
 We also studied the serum levels and intake of vi-
tamin D. Vitamin D has no antioxidant capacity, but an 
effect of vitamin D on severe exacerbation of asthma has 
been observed.48 Brumpton et al. reported that low vita-
min D is associated with lung function decline in adult 
patients with asthma.49 We could not find any correlation 
between pulmonary functions and either the serum lev-
els or intake of vitamin D (data not shown). The protec-
tive effects with exacerbation were not observed because 
of the short period of this study.  
 In this study, α-tocopherol was slightly above the 
normal range and γ-tocopherol was within normal range. 
Kodama et al. reported the concentration of α-tocopher-
ol in patients with asthma was not significantly different 
from control subjects.50 The reason for the inconsistency 
with our study is not known. On the other hand, Cook-
Mills J et al. reported that the risk of asthma is increased 
in low levels of α-tocopherol with high levels of γ-to-
copherol.51 Again, further study is necessary to clarify 
the relationships between α-tocopherol and γ-tocopherol 
in patients with established asthma. 
 It has been reported that transient exercise increas-
es both oxidative stress and antioxidant capacity.25, 26 
Furthermore, exercise training increases antioxidant ca-
pacity.52 In this study, we could not find any significant 
relationship between daily activity and oxidative stress 
level. Since our study evaluated average daily activity 
over a short period without exercise, and we did not 
compare the individual differences with activity level, 
further study is needed to show how either daily activity 
or exercise might influence oxidative stress on the same 
day in a single subject with asthma.
 In this study, FEV1/FVC was positively correlated 
with activity counts per minute. Although FEV1/FVC 
was not correlated with total activity, activity counts per 
minutes were positively correlated with total activity (data 
not shown). Probably, patients who show better FEV1/
FVC are likely to have more physical activity. Physical 
activity is reduced in patients with severe asthma.53 
Furthermore, Brumpton et al. reported that the decline 
in FEV1 was less in physically active patients with asth-
ma.54 In their study, physical activity was measured by 
self-reporting. Therefore, it might be useful to study the 
relationship between physical activity and pulmonary 
function by using actigraphy. 
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 In conclusion, we have found no relationships among 
oxidative stress, antioxidant capacity, vitamin levels, and 
physical activity in patients with asthma. In a real life 
setting with a short-term evaluation, oxidative stress may 
not be affected by daily activity and by antioxidant nu-
trition intake. A large and longitudinal prospective study 
is necessary to confirm our results. 
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